THE CHANGING FACE OF CHOLESTEROL MANAGEMENT

The Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Healthcare 2006 Quarterly Analyst Briefing Presentation on the U.S. Cholesterol Drug market to be held on Thursday, February 16, 2006 at 2:00pm CST / 3:00pm EST. Highlights of the briefing will include: market overview and forecast, new treatment trends, selected recent important events as well as product highlights. The statin class has now reached maturation, and pipeline development has moved into other market areas. With four statin products facing their generic counterparts in the next five years, it is up to new therapeutic trends and technology innovation to generate the blockbuster products of the future.
PR Newswire